-The Telegraph New Delhi: A scientific panel has identified flaws in India's existing regulatory system that governs genetically modified (GM) crops and called for an indefinite moratorium on trials of GM food crops until the regulatory system is fixed. The regulatory system, which the Indian government has used to process dossiers of several GM crops, has "major gaps" and will require "rethinking, investment, and relearning to fix," a technical expert committee (TEC)...

-Economic and Political Weekly The Chhapra tragedy must ask us how we can improve public services, not scrap them altogether. In the aftermath of the ghastly tragedy in Chhapra, Bihar, where 22 children lost their lives after they consumed a government-provided school meal containing organophosphate pesticides, we must demand of the State a far greater commitment to administering large-scale welfare programmes that are meant to improve, not destroy the life of citizens....

-The Business Standard The tragedy involving the death of children in a Bihar school should reinforce recent efforts to improve the programme, notes Amarjeet Sinha. The sad loss of 23 innocent lives after consuming hot cooked meals in a school in Bihar has rightly shocked and angered people. The highly poisonous pesticide monocrotophos found in children's food and a headmistress overlooking the cook and the children's protests about the oil and not...

-The Economic Times NEW DELHI: A technical committee appointed by the Supreme Court (SC) has recommended an indefinite moratorium on open field trials of genetically-modified (GM) crops till the deficiencies in the regulatory and safety systems are effectively addressed. The recommendations, if accepted by the court, would have a serious impact on the commercialisation of GM crops. In its final report, which was submitted to the court last week, the six-member...

-The Economic Times Over a year ago, I had written a piece, Quo Vadis, Indian Pharma? (ET, May 11, 2012), in this column. Some key issues were highlighted in the article. Perhaps it is time to revisit the subject and bring out some current issues. Price control: Hurray, the department of pharmaceuticals has come out with a new non-intrusive price control methodology, moving from the cost-based model to the average market price...